CorrlensCorrlens
Correlate

Correlation Analysis

Biogen Inc. Common Stock vs Johnson & Johnson

BIIB vs JNJ

-0.108

Weak inverse

When one moves up, the other tends to move down.

BIIB logo

Biogen Inc. Common Stock

BIIB

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

Market cap 25.3B · 7,500 employees

JNJ logo

Johnson & Johnson

JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Market cap 580.4B

Apr 9, 2021 — Apr 7, 2026Daily1,253 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: BIIBGray: JNJ36 of 1,253 points (sampled)

Who Moves First

BIIB leads JNJ by 6 days

BIIB tends to move before JNJ.

After testing 13 timing shifts, the strongest relationship was -0.123 (they moved in opposite directions).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.018

10 periods · Return correlation when both series rose

Both Falling

+0.424

10 periods · Return correlation when both series fell

Diverging

-0.639

15 periods · Return correlation when series moved apart

R-Squared

1.2%

Share of variance in one series explained by the other.

Trend Agreement

62.6%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,253

Deep shared window — 1,253 usable pairs.

Significance

p < 0.001

95% CI: [-0.162, -0.053]

Scatter

XY Regression

102.6150200250300342.9135.5140160180200220240252.6Biogen Inc. Common StockJohnson & JohnsonData pointsFit (r = -0.108)

Pipeline

Data quality details

Pipeline Summary

1,253 paired data points survived the daily window.

Raw input

1,253

1,254

Normalized

1,253

1,254

Prepared

1,253

1,254

Aligned

1,253

1,253

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

1

A: 0 / B: 1

Series A

BIIB logo

Biogen Inc. Common Stock

BIIB

Market cap 25.3B · 7,500 employees

Stock · 1,253 raw → 1,253 prepared

Series B

JNJ logo

Johnson & Johnson

JNJ

Market cap 580.4B

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

17

Estimated crossover points between normalized spreads.

Slope

-0.0353

Linear regression slope.

Intercept

176.3810

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 4 hours ago · ID: stock-biib-vs-stock-jnj-daily